Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Conway

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The Journal of Infectious Diseases|June 1, 1993
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and controlJ A Jernigan, B S Lowry, F G Hayden, et al.
American Journal of Medical Genetics|November 1, 1987
Deletion (13)(q14.1q14.3) in two generations: variability of ocular manifestations and definition of the phenotypeW G Wilson, P A Campochiaro, B P Conway, et al.
American Journal of Human Genetics|July 1, 1993
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsinJ P Macke, C M Davenport, S G Jacobson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1980
Rapid regression of pituitary prolactinomas during bromocriptine treatmentM O Thorner, W H Martin, A D Rogol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomesC L Slingluff, G Yamshchikov, P Neese, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The Journal of Infectious Diseases|June 1, 1993
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and controlJ A Jernigan, B S Lowry, F G Hayden, et al.
American Journal of Medical Genetics|November 1, 1987
Deletion (13)(q14.1q14.3) in two generations: variability of ocular manifestations and definition of the phenotypeW G Wilson, P A Campochiaro, B P Conway, et al.
American Journal of Human Genetics|July 1, 1993
Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsinJ P Macke, C M Davenport, S G Jacobson, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1980
Rapid regression of pituitary prolactinomas during bromocriptine treatmentM O Thorner, W H Martin, A D Rogol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomesC L Slingluff, G Yamshchikov, P Neese, et al.
Pageof 4